Clinical Trial Update: Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating study design to combine dinutuximab beta with two chemotherapy regimens for neuroblastoma; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• dinutuximab beta (dinutuximab beta)

Snippet

Sponsor: Princess Maxima Center for Pediatric Oncology | Conditions: Neuroblastoma | Phase 1 | Status: RECRUITING